Ad is loading...
BPMC
Price
$96.62
Change
+$1.81 (+1.91%)
Updated
Nov 21 closing price
83 days until earnings call
RCKT
Price
$12.79
Change
-$0.25 (-1.92%)
Updated
Nov 21 closing price
104 days until earnings call
Ad is loading...

BPMC vs RCKT

Header iconBPMC vs RCKT Comparison
Open Charts BPMC vs RCKTBanner chart's image
Blueprint Medicines
Price$96.62
Change+$1.81 (+1.91%)
Volume$778.93K
CapitalizationN/A
Rocket Pharmaceuticals
Price$12.79
Change-$0.25 (-1.92%)
Volume$1.34M
CapitalizationN/A
BPMC vs RCKT Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BPMC vs. RCKT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a StrongBuy and RCKT is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BPMC: $96.62 vs. RCKT: $12.79)
Brand notoriety: BPMC and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 119% vs. RCKT: 134%
Market capitalization -- BPMC: $6.02B vs. RCKT: $1.17B
BPMC [@Biotechnology] is valued at $6.02B. RCKT’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both BPMC and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • BPMC’s TA Score: 4 bullish, 6 bearish.
  • RCKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а +1.01% price change this week, while RCKT (@Biotechnology) price change was -13.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

BPMC is expected to report earnings on Feb 13, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($6.02B) has a higher market cap than RCKT($1.17B). BPMC YTD gains are higher at: 4.748 vs. RCKT (-57.324). BPMC has higher annual earnings (EBITDA): -75.58M vs. RCKT (-247.25M). BPMC has more cash in the bank: 734M vs. RCKT (236M). RCKT has less debt than BPMC: RCKT (25.6M) vs BPMC (471M). BPMC has higher revenues than RCKT: BPMC (434M) vs RCKT (0).
BPMCRCKTBPMC / RCKT
Capitalization6.02B1.17B517%
EBITDA-75.58M-247.25M31%
Gain YTD4.748-57.324-8%
P/E RatioN/AN/A-
Revenue434M0-
Total Cash734M236M311%
Total Debt471M25.6M1,840%
FUNDAMENTALS RATINGS
BPMC vs RCKT: Fundamental Ratings
BPMC
RCKT
OUTLOOK RATING
1..100
1951
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4690
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for BPMC (80). This means that RCKT’s stock grew somewhat faster than BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (67) in the Biotechnology industry is somewhat better than the same rating for RCKT (100). This means that BPMC’s stock grew somewhat faster than RCKT’s over the last 12 months.

BPMC's SMR Rating (97) in the Biotechnology industry is in the same range as RCKT (97). This means that BPMC’s stock grew similarly to RCKT’s over the last 12 months.

BPMC's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for RCKT (90). This means that BPMC’s stock grew somewhat faster than RCKT’s over the last 12 months.

BPMC's P/E Growth Rating (74) in the Biotechnology industry is in the same range as RCKT (100). This means that BPMC’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCRCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
73%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSMLX30.630.52
+1.73%
Principal SmallCap R6
APHNX15.990.11
+0.69%
Artisan Select Equity Institutional
CIICX36.590.04
+0.11%
American Funds Intl Gr and Inc 529C
MSERX10.63N/A
N/A
MassMutual Small Cap Growth Eq R4
IJPTX12.39-0.04
-0.32%
VY® JPMorgan Emerging Markets Equity S2

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with AXON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-1.92%
AXON - RCKT
52%
Loosely correlated
+3.52%
DNLI - RCKT
52%
Loosely correlated
-0.82%
ALEC - RCKT
51%
Loosely correlated
+3.44%
PLRX - RCKT
51%
Loosely correlated
+0.94%
NTLA - RCKT
51%
Loosely correlated
+5.18%
More